In vitro differentiation and propagation of urothelium from pluripotent stem cell lines

Stephanie L. Osborn; Eric A Kurzrock

doi:10.1007/978-1-4939-7234-0_11

In vitro differentiation and propagation of urothelium from pluripotent stem cell lines

Stephanie L. Osborn, Eric A Kurzrock

Urology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Bioengineering of bladder tissue, particularly for those patients who have advanced bladder disease, requires a source of urothelium that is healthy, capable of significant proliferation in vitro and immunologically tolerated upon transplant. As pluripotent stem cells have the potential to fulfill such criteria, they provide a critical cell source from which urothelium might be derived in vitro and used clinically. Herein, we describe the in vitro differentiation of urothelium from the H9 human embryonic stem cell (hESC) line through the definitive endoderm (DE) phase via selective culture techniques. The protocol can be used to derive urothelium from other hESCs or human-induced pluripotent stem cells.

Original language	English (US)
Title of host publication	Methods in Molecular Biology
Publisher	Humana Press Inc.
Pages	137-144
Number of pages	8
Volume	1655
DOIs	https://doi.org/10.1007/978-1-4939-7234-0_11
State	Published - 2018

Publication series

Name	Methods in Molecular Biology
Volume	1655
ISSN (Print)	1064-3745

Fingerprint

Keywords

Activin A
Bladder bioengineering
Definitive endoderm
Human embryonic stem cells
Induced pluripotent stem cells
Uroplakins
Urothelium

ASJC Scopus subject areas

Molecular Biology
Genetics

Cite this

Osborn, S. L., & Kurzrock, E. A. (2018). In vitro differentiation and propagation of urothelium from pluripotent stem cell lines. In Methods in Molecular Biology (Vol. 1655, pp. 137-144). (Methods in Molecular Biology; Vol. 1655). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-7234-0_11

@inbook{3a56f724491f4a0ab47e2cab936616de,

title = "In vitro differentiation and propagation of urothelium from pluripotent stem cell lines",

abstract = "Bioengineering of bladder tissue, particularly for those patients who have advanced bladder disease, requires a source of urothelium that is healthy, capable of significant proliferation in vitro and immunologically tolerated upon transplant. As pluripotent stem cells have the potential to fulfill such criteria, they provide a critical cell source from which urothelium might be derived in vitro and used clinically. Herein, we describe the in vitro differentiation of urothelium from the H9 human embryonic stem cell (hESC) line through the definitive endoderm (DE) phase via selective culture techniques. The protocol can be used to derive urothelium from other hESCs or human-induced pluripotent stem cells.",

keywords = "Activin A, Bladder bioengineering, Definitive endoderm, Human embryonic stem cells, Induced pluripotent stem cells, Uroplakins, Urothelium",

author = "Osborn, {Stephanie L.} and Kurzrock, {Eric A}",

year = "2018",

doi = "10.1007/978-1-4939-7234-0_11",

language = "English (US)",

volume = "1655",

series = "Methods in Molecular Biology",

publisher = "Humana Press Inc.",

pages = "137--144",

booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - In vitro differentiation and propagation of urothelium from pluripotent stem cell lines

AU - Osborn, Stephanie L.

AU - Kurzrock, Eric A

PY - 2018

Y1 - 2018

N2 - Bioengineering of bladder tissue, particularly for those patients who have advanced bladder disease, requires a source of urothelium that is healthy, capable of significant proliferation in vitro and immunologically tolerated upon transplant. As pluripotent stem cells have the potential to fulfill such criteria, they provide a critical cell source from which urothelium might be derived in vitro and used clinically. Herein, we describe the in vitro differentiation of urothelium from the H9 human embryonic stem cell (hESC) line through the definitive endoderm (DE) phase via selective culture techniques. The protocol can be used to derive urothelium from other hESCs or human-induced pluripotent stem cells.

AB - Bioengineering of bladder tissue, particularly for those patients who have advanced bladder disease, requires a source of urothelium that is healthy, capable of significant proliferation in vitro and immunologically tolerated upon transplant. As pluripotent stem cells have the potential to fulfill such criteria, they provide a critical cell source from which urothelium might be derived in vitro and used clinically. Herein, we describe the in vitro differentiation of urothelium from the H9 human embryonic stem cell (hESC) line through the definitive endoderm (DE) phase via selective culture techniques. The protocol can be used to derive urothelium from other hESCs or human-induced pluripotent stem cells.

KW - Activin A

KW - Bladder bioengineering

KW - Definitive endoderm

KW - Human embryonic stem cells

KW - Induced pluripotent stem cells

KW - Uroplakins

KW - Urothelium

UR - http://www.scopus.com/inward/record.url?scp=85029354023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029354023&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-7234-0_11

DO - 10.1007/978-1-4939-7234-0_11

M3 - Chapter

C2 - 28889383

AN - SCOPUS:85029354023

VL - 1655

T3 - Methods in Molecular Biology

SP - 137

EP - 144

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -

Access to Document

10.1007/978-1-4939-7234-0_11